REFRACTORY - The disclosed invention relates to a refractory made from an as-batched composition comprising alumina, a rare earth oxide, and optionally an oxide of a transition metal comprising Sc, Zn, Ga, Y, Cd, In, Sn, Tl or a mixture of two or more thereof, the refractory being characterized by the absence of SiO

2011-01-27

20110021341

Adsorbents for Organosulfur Compound Removal from Fluids - A method for separating organosulfur compounds from a liquid is provided. The method of this embodiment comprises contacting the liquid with the microporous coordination polymer to form a MCP-organosulfur inclusion compound.

2011-01-27

20110021342

Method for Making RU-SE and RU-SE-W Nanometer Catalyst - A method is disclosed for making Ru—Se and Ru—Se—W catalyst. In the method, carrier is processed with strong acid and poured into first ethylene glycol solution. Ultra-sonication and high-speed stirring are conducted on the first ethylene glycol solution, thus forming carbon paste. The carbon paste is mixed with second ethylene glycol solution containing at least one nanometer catalyst precursor and an additive. High-speed stirring is conducted to form mixture. The mixture is heated so that Ru—Se catalyst is reduced. The mixture is filtered to separate the carrier. Then, the carrier is washed with de-ionized water. Conducting drying and hydrogen reduction are conducted to make the Ru—Se catalyst on the carrier.

2011-01-27

20110021343

Methods of Preparation of an Olefin Oligomerization Catalyst - A method of making a catalyst for use in oligomerizing an olefin comprising a chromium-containing compound, a pyrrole-containing compound, a metal alkyl, a halide-containing compound, and optionally a solvent, the method comprising contacting a composition comprising the chromium-containing compound and a composition comprising the metal alkyl, wherein the composition comprising the chromium-containing compound is added to the composition comprising the metal alkyl.

2011-01-27

20110021344

Method for preparing non-metallocene ligands - A method of preparing supported catalysts useful for olefin polymerization is described. The catalysts comprise a Group 4 metal complex that incorporates a tridentate dianionic ligand. An activator mixture is first made from a boron compound having Lewis acidity and an excess of an alumoxane. The activator mixture is then combined with a support and the Group 4 metal complex to give a supported catalyst. The method provides an active, supported catalyst capable of making high-molecular-weight polyolefins.

Molecule Recognizing Material And Process For Producing The Molecule Recognizing Material - The present invention provides a new molecular recognition material, wherein the control of morphology is possible and the selectivity and capture efficiency of the template molecule are excellent, and to provide a simple production method thereof. The molecular recognition material of the present invention is a core-shell particle, which has a shell layer on the core particle surface, and the material is characterized in that template molecules are imprinted on the above-described shell layer. And a production method of the molecular recognition material of the present invention comprising: (a) introducing an iniferter group on the core particle surface, (b) adsorbing the template molecule, after process (a), onto the core particle surface, and (c) forming the shell layer, after process (b), on the core particle surface.

2011-01-27

20110021348

CARBON NANOTUBE BINDING PEPTIDES - Peptides have been generated that have binding affinity to carbon nanostructures and particularly carbon nanotubes. Peptides of or the invention are generally about twelve amino acids in length. Methods for generating carbon nanotube binding peptides are also disclosed.

LIQUID SULFONYLUREA HERBICIDE FORMULATIONS - Disclosed are single liquid-phase herbicide compositions comprising by weight from 0.1 to 30% of one or more sulfonylurea herbicides, from 0 to 40% of one or more biologically active agents other than sulfonylurea herbicides, from 0 to 30% of one or more herbicide safeners, from 10 to 99.9% of one or more polyalkoxylated triglycerides wherein no more than about 50% by weight of the fatty acid-derived moieties in the polyalkoxylated triglycerides are derived from hydroxy fatty acids, from 0 to 89.9% of one or more fatty acid esters of C

2011-01-27

20110021351

HERBICIDAL COMPOUNDS - The present invention relates to a method of controlling plants or inhibiting plant growth which comprises applying to the plants or to the locus thereof a herbicidally effective amount of a compound of formula (I) wherein R

2011-01-27

20110021352

HERBICIDAL COMPOUNDS - The present invention relates to novel herbicidal [1,8]-naphthyridines of Formula (Ia) or (Ib), or an agronomically acceptable salt of said compound wherein R

METHODS OF REDUCING WEEDS AND KITS THEREFOR - Method for reducing weed on a weed-infested turfgrass. Said method comprising applying to the turfgrass an effective amount of a herbicidal fungus formulated into particles, most of the particles having a particle size of less than about 1.7 mm of diameter, whereas the herbicidal fungus decreases weed growth and/or increases weed disease development in the weed-infested turfgrass as compared to in the absence thereof; other embodiments of the methods comprising applying to the turfgrass an effective amount of a herbicidal fungus formulated into particles, and covering the weed-infested turfgrass with a ground cover sheet, whereas the herbicidal fungus and the ground cover sheet decrease weed growth and/or increases weed disease development in the weed-infested turfgrass as compared to in the absence thereof. Herbicidal fungus and kits therefore.

Herbicidal Compositions Comprising Pyroxasulfone VII - The present invention relates to herbicidally active compositions, which comprise 3-[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole [common name pyroxasulfone] and at least one herbicide B and at least one herbicide B which is selected from group consisting of synthetic auxins and auxin transport inhibitors.

2011-01-27

20110021357

CONTROL OF HARMFUL ALGAL BLOOMS BY INDUCTION OF PROGRAMMED CELL DEATH - The subject invention pertains to compositions, apparatus, and methods for controlling harmful algae and harmful algal bloom (HAB) based on the induction of the programmed cell death (PCD; apoptosis) pathway in the harmful algae, and to kits for determining algal susceptibility to PCD induction.

EMULSIFIABLE CONCENTRATE COMPOSITION - Disclosed is an emulsifiable concentrate composition characterized by containing not less than 0.5% by weight but not more than 50% by weight of a hydrophobic agrochemically active compound, not less than 5% by weight but not more than 15% by weight of a surfactant, not less than 2% by weight but not more than 60% by weight of an aromatic hydrocarbon solvent, not less than 2% by weight but not more than 40% by weight of methyl oleate, and not less than 12% by weight but not more than 90% by weight of 1,3-dimethyl-2-imidazolidinone. The emulsion composition is also characterized in that the weight ratio of 1,3-dimethyl-2-imidazolidinone to methyl oleate is within the range from 1:0.03 to 1:2.

2011-01-27

20110021360

Superconductive nanocomposite - The superconductive nanocomposite is a composition formed by nanoparticles of a high temperature superconductor blended with a polymer matrix containing natural rubber and polyethylene. The high temperature superconductor is preferably a bismuth-based superconductor (BSCCO) having a particle size of about 21 nm, but may be any other high temperature or Type II ceramic, metal oxide superconductor. The superconductor nanoparticles comprise about 15% of the weight of natural rubber in the composition. The polyethylene is preferably low density polyethylene and may comprise between 0% up to about 40% of the weight of natural rubber in the composition. The nanocomposite may be prepared by blending the components and roll milling the rubber. Depending upon the percentage of polyethylene present in the matrix, the nanocomposite has useful applications as a double thermistor (both positive and negative coefficients of electrical resistivity), for antistatic charge dissipation, and for electromagnetic shielding in the microwave region.

2011-01-27

20110021361

Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids - A method of sorting mixtures of nucleic acid strands comprising hybridizing the strands to an array of immobilized oligonucleotides, each of which includes a constant segment adjacent to a variable segment. The constant segment of the immobilized oligonucleotides can be made complementary to the ends of strands obtained by digesting a double-stranded nucleic acid with a restriction enzyme and restoring the restriction sites, thereby permitting the sorting of strands according to their variable sequences adjacent to their constant terminal restored restriction sites.

APPARATUS AND METHOD COMPRISING A SENSOR ARRAY AND A POROUS PLUNGER AND USE THEREOF - Disclosed is an apparatus that is used for detecting liquids or substances from liquids and includes a plunger that has a porous plunger layer which is pressed onto a sensor array. Each sensor of the sensor array is surrounded by elevations which spatially separate the sensors from each other like walls. In at least one embodiment, when the plunger layer is pressed onto the sensor array, the walls are pressed into the pores of the plunger layer. Liquid-tight connections are created between the walls and the plunger layer while liquid remains over the sensors. The liquid can be measured. In at least one embodiment, when there is direct mechanical contact between the plunger layer and the sensors, the liquid over the sensors is located in open pores on the surface of the plunger layer. No liquid flows between the pores and across the walls when pressure is applied to the plunger layer such that closed reaction chambers are created.

2011-01-27

20110021364

PREDICTIVE TEST FOR ADULT DOG BODY SIZE - The invention provides a method of predicting the size of a dog that will be attained in adulthood, comprising typing the nucleotide(s) present for a single nucleotide polymorphic (SNP) marker present in the genome of the dog at a position equivalent to position 201 in one or more of the sequences identified in Table 1, and/or at one or more positions which are in linkage disequilibrium with any one of these positions, and thereby predicting the size of the dog that will be attained in adulthood.

METHODS FOR THRESHOLD DETERMINATION IN MULTIPLEXED ASSAYS - Methods for determination of threshold values of signatures comprised in an assay are described. Each signature enables detection of a target. The methods determine a probability density function of negative samples and a corresponding false positive rate curve. A false positive criterion is established and a threshold for that signature is determined as a point at which the false positive rate curve intersects the false positive criterion. A method for quantitative analysis and interpretation of assay results together with a method for determination of a desired limit of detection of a signature in an assay are also described.

2011-01-27

20110021369

SINGLE CELL BASED REPORTER ASSAY TO MONITOR GENE EXPRESSION PATTERNS WITH HIGH SPATIO-TEMPORAL RESOLUTION - The invention relates to a double-stranded polynucleotide comprising on its positive strand considered from its 5′ end to its 3′ end, (i) a promoter of a gene of interest or several promoters of various genes of interest selected among genes which are endogenous to a determined cell, and, (ii) one or several barcode(s) wherein each barcode contains at least one barcode unit formed of at least one, especially of multiple, recognition binding sites each binding site being composed of a nucleotide sequence, and wherein each of said barcode(s) is under the control of at least one of said promoter(s) for transcription. It further concerns use of said polynucleotide to monitor gene expression patterns in living cells, especially in single cells, with a rapid and high spatio-temporal resolution.

2011-01-27

20110021370

SALIVARY PROTEIN BIOMARKERS FOR HUMAN ORAL CANCER - The present invention relates to the identification of novel oral cancer and periodontal disease biomarkers. Further, the present invention provides novel methods of diagnosing and for providing a prognosis for oral cancer and periodontal disease. The present invention additionally provides novel methods of distinguishing between oral cancer and periodontal disease. Finally, kits are provided that find use in the practice of the methods of the invention.

2011-01-27

20110021371

DNA MICROARRAY BASED IDENTIFICATION AND MAPPING OF BALANCED TRANSLOCATION BREAKPOINTS - Methods for detecting and mapping chromosomal rearrangements associated with various diseases using comparative genomic hybridization are disclosed. Included are methods to identify translocation partners of known genomic loci and to determine translocation breakpoints. These methods may be used in the prognosis, diagnosis, and determination of predisposition to diseases that involve chromosomal rearrangements.

2011-01-27

20110021372

Compositions and methods for detection and isolation of phosphorylated molecules - The present invention relates to phosphate-binding compounds that find use in binding, detecting and isolating phosphorylated target molecules including the subsequent identification of target molecules that interact with phosphorylated target molecules or molecules capable of being phosphorylated. A binding solution is provide that comprises a phosphate-binding compound, an acid and a metal ion wherein the metal ion simultaneously interacts with an exposed phosphate group on a target molecule and the metal chelating moiety of the phosphate-binding compound forming a bridge between the phosphate-binding compound and a phosphorylated target molecule resulting in a ternary complex. The binding solution of the present invention finds use in binding and detecting immobilized and solubilized phosphorylated target molecules, isolation of phosphorylated target molecules from a complex mixture and aiding in proteomic analysis wherein kinase and phosphatase substrates and enzymes can be identified.

2011-01-27

20110021373

ANTIBODY CATEGORIZATION BASED ON BINDING CHARACTERISTICS - Methods for categorizing antibodies based on their epitope binding characteristics are described. Methods and systems for determining the epitope recognition properties of different antibodies are provided. Also provided are data analysis processes for clustering antibodies on the basis of their epitope recognition properties and for identifying antibodies having distinct epitope binding characteristics.

2011-01-27

20110021374

NMR DEVICE FOR DETECTION OF ANALYTES - This invention relates generally to detection devices having one or more small wells each surrounded by, or in close proximity to, an NMR micro coil, each well containing a liquid sample with magnetic nanoparticles that self-assemble or disperse in the presence of a target analyte, thereby altering the measured NMR properties of the liquid sample. The device may be used, for example, as a portable unit for point of care diagnosis and/or field use, or the device may be implanted for continuous or intermittent monitoring of one or more biological species of interest in a patient.

2011-01-27

20110021375

Sphingosine 1-Phosphate Receptor Gene, SPPR - A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.

2011-01-27

20110021376

Method for Analyzing a Glycomolecule - The invention relates generally the structural analysis of glycomolecule-containing macromolecules, such as those that occur either attached to proteins (proteoglycans, glycoproteins), lipids, or as free saccharides.

2011-01-27

20110021377

USE OF A TRPC CHANNEL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE - The invention refers to the use of a TRPC channel, an inactivating mutant thereof, or a nucleotide sequence coding for the TRPC channel or for the inactivating mutant for the production of a medicament for the treatment of a cardiovascular disease and a method of screening a modulator of the TRPC channel or an inactivating mutant thereof.

METHOD OF DESIGNING PRIMERS FOR USE IN METHOD OF DETECTING TARGET NUCLEIC ACID AND ASSAY KIT - Kits for use in a method of detecting an amplification product by hybridizing it with a probe, the amplification product is amplified from a target nucleic acid with the primers, including placing F3, F2 and F1 regions in this order from a 5′ terminal side and B3c, B2c and B1c regions in this order from a 3′ terminal side, and additionally an FP region in the region from the F2 to F1 regions and/or a BPc region in the region from the B2c to B1c regions in the target nucleic acid, determining the respective regions in such a manner that the FP and F2 regions and/or the BPc and B2c regions have an unoverlapping region of at least 10 bases or more and overlapping regions of 10 bases or less, and designing the primers according to the regions.

2011-01-27

20110021380

BIO-MICROARRAY AND A SUBSTRATE FOR USE THEREWITH - For the purpose of improving the accuracy of a variety analyses using a bio-microarray, it is a main object of the invention to provide a bio-microarray capable of producing relatively high signal intensity from a fluorescent molecule and capable of having improved quantification performance and to provide a substrate for bio-microarray.

siRNA targeting amyloid beta (A4) precursor protein (APP) - Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for APP.

2011-01-27

20110021383

APPARATUSES FOR REAL-TIME, SINGLE MOLECULE SEQUENCE DETERMINATION - A sequencing methodology is disclosed that allows a single DNA or RNA molecule or portion thereof to be sequenced directly and in substantially real time. The methodology involves engineering a polymerase and/or dNTPs with atomic and/or molecular tags that have a detectable property that is monitored by a detection system.

2011-01-27

20110021384

DRILLING FLUID ADDITIVE AND METHODS OF STABILIZING KAOLINITE FINES MIGRATION - A method of drilling is disclosed and includes pumping a wellbore fluid into a wellbore through an earth formation, wherein the wellbore fluid comprises a base fluid and a surface active agent capable of altering wettability of fines located in the earth formation, and allowing filtration of at least a portion of the wellbore fluid into the earth formation.

MICROEMULSION TO IMPROVE SHALE GAS PRODUCTION BY CONTROLLING WATER IMBIBITION - The invention provides a method for treating tight gas sand and shale subterranean formations, the method comprising: forming a solvent-surfactant blend by combining a solvent, a surfactant and a co-surfactant; adding a diluent to the solvent-surfactant blend to form a micro emulsion; wherein the wettability of the formation altered from water-wet to gas-wet, and the amount of water imbibed into the formation is reduced.

2011-01-27

20110021387

REVERSIBLE GELLING SYSTEM AND METHOD USING SAME DURING WELL TREATMENTS - An all-oil reversible gelling system includes a polymer, a crosslinker, a gel accelerator, and an oxidant, wherein temperature activates the crosslinker so as to cause the system to form a gel, and the oxidant subsequently decomposes the gel. This gel is designed to seal temporarily portions of oil-producing or water or gas injecting subterranean formations.

2011-01-27

20110021388

Microemulsifiers and methods of making and using same - A method comprising contacting a zwitterionic surfactant, co-surfactant, and water to form a microemulsifier, and contacting the microemulsifier with an oleaginous fluid under low shear conditions to form a microemulsion. A method comprising introducing a first wellbore servicing fluid comprising at least one oleaginous fluid into a wellbore, wherein the first wellbore servicing fluid forms oil-wet solids and/or oil-wet surfaces in the wellbore, and contacting the oil-wet solids and/or oil-wet surfaces in the wellbore with a second wellbore servicing fluid comprising a zwitterionic surfactant, a co-surfactant, and a brine to form a microemulsion.

2011-01-27

20110021389

METHOD AND COMPOSITION FOR ENHANCED HYDROCARBONS RECOVERY - A method of treating a hydrocarbon containing formation, comprising (a) providing a hydrocarbon recovery composition to at least a portion of the hydrocarbon containing formation, wherein the hydrocarbon recovery composition comprises a propoxylated composition which comprises (1) a glycerol sulfonate of a propoxylated primary alcohol having a branched aliphatic group with an average carbon number from 10 to 24 and having an average number of branches per aliphatic group of from 0.7 to 2.5 and having at least 0.5, preferably from 3 to 12, moles of propylene oxide per mole of primary alcohol and (2) polypropylene glycol; provided that the primary alcohol is propoxylated by contacting the alcohol with propylene oxide in the presence of a catalytically effective amount of one or more of the phosphate salts of lanthanum series elements or the rare earth elements, preferably a carbonate salt thereof, wherein the propoxylated composition comprising the propoxylated alcohol and from 1 to 30 wt % of polypropylene glycol is produced; and (b) allowing the composition to interact with hydrocarbons in the hydrocarbon containing formation.

2011-01-27

20110021390

LOW FRICTION SLIDING MEMBER - The low friction sliding member includes a substrate and an amorphous hard carbon film formed on the surface of the substrate and makes sliding contact with a mating member under a wet oiling condition. The lubricant oil includes at least one of sulfur (S) and phosphorus (P) and at least one of zinc (Zn), calcium (Ca), magnesium (Mg), sodium (Na), barium (Ba) and copper (Cu). The amorphous hard carbon film comprises carbon (C) as a major component, and hydrogen (H) in the range from 5 to 25 atomic % and a predetermined amount of boron (B), aluminum (Al), manganese (Mn) or molybdenum (Mo) assuming that the total atomic % of the amorphous carbon film is 100.

2011-01-27

20110021391

GREASE COMPOSITION FOR USE IN CONSTANT VELOCITY JOINTS - A grease composition which has a good compatibility with boots made of rubber or thermoplastic elastomer, and which also gives enhanced endurance, low wear and low friction in use in constant velocity joints is disclosed. A grease composition is suggested comprising a) at least one base oil; b) 5% by weight to 40% by weight of at least one calcium sulphonate soap and/or calcium sulphonate complex soap as a thickener; and c) at least one molybdenum containing additive.

2011-01-27

20110021392

METHOD FOR PREPARING A LUBRICATING COMPOSITION - The present invention provides a method for preparing a lubricating composition, in particular a grease, the method at least comprising the steps of: a) providing a base oil composition optionally containing one or more additives; b) providing a solution of one or more alkyl-substituted quinolines or oligomeric derivatives thereof in a solvent; and c) adding the solution of step b) to the base oil composition of step a) at a temperature below 150° C.

LUBRICANT COMPOSITION - A lubricating oil composition comprising a lubricating base oil, and a mixture and/or a reaction product of (A) 0.01-0.5% by mass of at least one compound selected from among acid phosphates represented by formula (1) or formula (2), and (B) 0.01-2% by mass of an alkylamine represented by formula (3), based on the total weight of the composition, wherein the acid value due to component (A) is 0.1-1.0 mgKOH/g. [R

2011-01-27

20110021395

Trunk piston engine lubricating oil compositions - A trunk piston engine lubricating oil composition comprising (a) a major amount of a base stock comprising at least 90% by weight saturated hydrocarbons; and (b) a minor amount of a base oil having a viscosity index of less than 70 and a cycloaliphatic hydrocarbon content of at least about 25 wt. % is disclosed.

2011-01-27

20110021396

Fuel additive - A composition and method for improving the performance, and thus, also the fuel economy, of an internal combustion engine by introducing a fuel additive into the engine's fuel supply to enhance fuel lubricity. The composition can feature a mixture of esters, glycol ether, and a solvent. The mixture of esters can include adipate esters, azelate esters, dodecanedioate esters, sebacate esters, or phthalate esters. Esters that may be used to create the composition can include a mixture of two or more adipate esters such as, for example, an adipic acid ester, a glutaric acid ester, and a succinic acid ester. The composition can further feature a smoke suppressant that can be an organometallic soap. The organometallic soap can be an iron salt of a fatty acid such as, for example, ferrocene. The composition can be used as a combustion modifier fuel additive and as a lubricating oil.

2011-01-27

20110021397

Composition With A Color Marker - A composition comprising at least one indicator, at least one light stabilizer, and at least one antioxidant. The composition is useful as a cleanser that provides a usage timer based on color change to indicate to a user that sufficient time has elapsed for cleansing.

2011-01-27

20110021398

SKIN AND HAND CLEANSERS - The invention relates to skin and hand cleansers comprising the components a.) at least one alkyl ester and/or diester, b.) 0 to 40 wt.-% of at least one surfactant selected from the group of fatty alcohol ethoxylates, fatty alcohol ether sulfates and salts of sulfated and/pr sulfonated fatty acids, c.) at least one thixotropic agent and at least one hydrophilic, pyrogenic silicic acid, d.) 0 to 30 wt.-% of one or more abrasives, e.) 0 to 5 wt.-% of at least one physiologically compatible carbonic acid ester f.) 0 to <10 wt.-% water, g.) optionally one or more viscosity modifying agent, h.) optionally other cosmetic aids, additives and/or active ingredients, wherein the total of the components a.) through h.) adds up to 100 wt.-%, based on the composition of the cleanser.

SEMICONDUCTOR SURFACE TREATING AGENT COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SURFACE USING THE SEMICONDUCTOR SURFACE TREATING AGENT COMPOSITION - An object of the present invention is to provide a semiconductor surface treating agent composition, which can realize easy removing of an anti-reflection coating layer in a production process of a semiconductor device or the like at a low temperature in a short time, a method for treating a semiconductor surface using the same, and further a semiconductor surface treating agent composition, which can realize not only removing of both layer of an anti-reflection coating layer and a resist layer, but can realize even removing of a cured resist layer produced in an etching process, and a method for treating a semiconductor surface using the same. The semiconductor surface treating agent composition of the present invention is characterized by comprising a compound which generates a fluorine ion in water, a carbon radical generating agent, and water and optionally an organic solvent, and the method for treating a semiconductor surface of the present invention is characterized by using the composition.

2011-01-27

20110021401

Method of treating drains using fungus cultures - A method of treating drain systems containing organic matter and providing a pesticide for killing insects is provided. Introducing a bacterial culture into a drain system that is operable to metabolize organic matter will reduce the quantity of the organic matter in the drain system. Introducing a biocidal amount of fungus culture such as,

2011-01-27

20110021402

Detergent Composition - A solid detergent composition having the salt of an anionic surfactant and of a monopropanolamine counterion.

2011-01-27

20110021403

NOVEL FORMULATION OF A WARE WASHING SOLID CONTROLLING HARDNESS - A water hardness controlling agent includes a polyacrylic acid or salt thereof having a molecular weight of between about 1,000 and about 50,000 g/mol, an acrylic-maleic acid copolymer or salt thereof having a molecular weight of between about 1,000 and about 100,000 g/mol and a phosphonocarboxylic acid or salt thereof. A ratio of acrylic-maleic acid copolymer or salt thereof to polyacrylic acid or salt thereof to phosphonocarboxylic acid or salt thereof in parts per million is about 1-30:10-80:6-20.

2011-01-27

20110021404

Surface Active Bleach and Dynamic pH - The present invention provides methods and compositions for dynamic pH control, particularly in detergent applications. In particularly preferred embodiments, the detergent compositions find use in surface removal of soils from fabrics, including clothing. In some particularly preferred embodiments, the present invention provides combinations of enzymes to provide for dynamic pH control.

2011-01-27

20110021405

Continuous Process for Making a Laundry Detergent Composition - A continuous process for making a solid particulate laundry detergent composition having the steps of: (a) forming a soft surfactant particle having a cake strength of from about 30N to about 200N; and (b) contacting the soft surfactant particle with a free-flowing heterogeneous particulate mixture having multiple chemically distinct detergent particle populations, wherein said free-flowing heterogeneous particulate mixture has a cake strength of from about 0N to about 20N, wherein the free-flowing heterogeneous particulate mixture has a weight average particle size of from about 50 micrometers to 2000 micrometers, and wherein the ratio of (i) the cake strength of the soft surfactant particle in N to (ii) the time between step (a) and step (b) in minutes is in the range of from 6Nmin

USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS - The present invention relates to the use of metal complex compounds having hydrazide ligands as oxidation catalysts. Further aspects of the invention are formulations comprising such metal complex compounds, novel metal complex compounds and novel ligands. The metal complex compounds are used especially for enhancing the action of peroxides, for example in the treatment of textile material, without at the same time causing any appreciable damage to fibres and dyeings. There is also no appreciable damage to fibres and dyeings if these metal complexes are used in combination with an enzyme or a mixture of enzymes.

2011-01-27

20110021408

COMPOSITIONS CONTAINING BENEFIT AGENT DELIVERY PARTICLES - The present disclosure relates to benefit agent delivery particles containing at least one benefit agent and at least one cellulosic polymer. The disclosure further relates to compositions containing benefit agent delivery particles and processes for making and using such compositions. The disclosure further relates to methods of imparting a benefit delivery capability to a cleaning composition.

2011-01-27

20110021409

Detergents and Cleaning Agents Comprising Porous Polyamide Particles - Detergents and cleaning agents containing porous polyamide particles that allow larger amounts of liquids such as scented oil to be absorbed such that liquid active substances can easily be incorporated into corresponding detergents and cleaning agents. The porous polyamide particles allow the incorporated liquids to be released in a delayed manner.

2011-01-27

20110021410

NOVEL FORMULATION OF A WARE WASHING SOLID CONTROLLING HARDNESS - A water hardness controlling agent includes a polyacrylic acid or salt thereof having a molecular weight of between about 1,000 and about 50,000 g/mol, an acrylic-maleic acid copolymer or salt thereof having a molecular weight of between about 1,000 and about 100,000 g/mol and a phosphonocarboxylic acid or salt thereof. A ratio of acrylic-maleic acid copolymer or salt thereof to polyacrylic acid or salt thereof to phosphonocarboxylic acid or salt thereof in parts per million is about 1-30:10-80:6-20.

2011-01-27

20110021411

REVERSE PROTEIN - A protein which is composed N-terminally of one or several C-terminal parts of the amino acid sequence of the mature tumour necrosis factor and C-terminally of one or several N-terminal parts of the amino acid sequence of the mature tumour necrosis factor, which activates epithelial ion channels and improves the lung function and which can be used for the manufacture of medicaments for the treatment of diseases associated with the lung function, such as oedemas.

2011-01-27

20110021412

Human Receptor Proteins; Related Reagents and Methods - Nucleic acids encoding mammalian, e.g., primate or rodent receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.

2011-01-27

20110021413

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION - Methods of suppressing the activation of microglial cells in the Central Nervous System (CNS), methods of ameliorating or treating the neurological effects of cerebral ischemia or cerebral inflammation, and methods of combating specific diseases that affect the CNS by administering a compound that binds to microglial receptors and prevents or reduces microglial activation are described. Also described are methods of screening compounds for the ability to suppress or reduce microglial activation.

2011-01-27

20110021414

Chimeric Phage Tail Proteins and Uses Thereof - A multi-protein pyocin-like structure derived from a bacteriophage or a bacteriocin that includes a chimeric tail fiber having a protein receptor binding domain capable of recognizing Lipid A. A multiprotein pyocin-like structure, derived from a bacteriophage or a bacteriocin that includes a chimeric tail fiber capable of recognizing and binding MurNac-L-Ala-D-Glu. A phage including a chimeric tail fiber that binds Lipid A. A plasmid encoding a chimeric ail fiber that binds MurNac-L-Ala-D-Glu. A plasmid encoding a chimeric tail fiber that binds Lipid A. A chimeric bacteriocin or bacteriophage derived tail fiber that includes the amino terminal of the human bactericidal/permeability-increasing protein (BPINTD)—A chimeric bacteriophage or bacteriocin derived tail fiber also includes a binding domain encoding the mammalian Nod2cτD—An antibacterial agent includes a bacteriocidal/permeability-increasing protein receptor domain that binds to Lipid A. An antibacterial agent also includes Nod2 carboxyl-terminus receptor domain that binds MurNac-L-Ala-D-Glu.

2011-01-27

20110021415

ANTIMICROBIAL PEPTIDES - The present invention relates to peptides comprising amino acids according to Formula I

ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE - Haptoglobin (Hp) removes cell-free Hemoglobin (Hb), with different physiological effects depending on the particular Hp polymer. We propose that material enriched for alpha 1 chain Hp polymeric forms, such as those made from Cohn fraction V precipitate, will be more suitable for the treatment of certain diseases benefiting from both an antioxidant and anti-inflammatory component, such as for hemolytic disease. Material enriched for alpha-2 chain Hp polymeric forms, made for example from Cohn fraction IV precipitate, will be more suitable for treatment of diseases where an angiogenic, and/or inflammatory affect, and/or limited extravasation is desirable.

MODIFICATION OF FEEDING BEHAVIOUR - The present invention relates to compositions and methods for use in the prevention or treatment of excess weight in a mammal. The compositions comprise oxyntomodulin which is shown to reduce food intake and/or increase energy expenditure.

2011-01-27

20110021421

LIQUID ENTERAL NUTRITIONAL COMPOSITION WITH A LOW SPECIFIC PROTEIN VOLUME - The present invention concerns liquid enteral nutritional compositions that comprise intact protein with a low specific volume allowing the preparation of nutrition with high protein and energy contents which are particularly advantageous for persons that are in, or recovering from, a disease state, persons that are malnourished or sportsmen and women and active elderly.

2011-01-27

20110021422

METHOD AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF DIABETIC AND AGED SKIN - Method and compositions are provided for treating or preventing a skin pathology or disorder associated with diabetes and/or aging, by topical administration of at least one agent capable of restoring an impaired physiological condition of the skin associated with said skin pathology or disorder. Examples of such agents include PKC modulating agents, various adipokines and insulin signaling related molecules. In particular, restoration of the subcutaneous adipose tissue can overcome many of the diabetic skin pathologies and aging skin disorders and conditions.

2011-01-27

20110021423

Rapid Acting Insulin Analogues - The invention is related to fast acting insulin analogues which can form soluble mix-tures (pre-mixed or self-mixed) with long acting insulin analogues. The fast action is achieved through monomerizing substitutions/deletions in the C-terminus of the B-chain of human insulin and the mixability with long acting insulin analogues is achieved through a substitution of the Zn-binding His in position B10 of human insulin with a Gln amino acid residue. In one embodiment the invention is related to fast acting insulin analogues in which at least one of the natural amino acid residues in position B22-B30 in the human B-chain has been substituted with another amino acid residue having the effect of promoting formation of the monomeric form of insulin, the His amino acid residue in position 10 in the B-chain is substituted with a Gln and wherein further one or more of the amino acid residues in position B22-B30 optionally have been deleted.

METHODS FOR TREATMENT OF PAIN - The invention provides for methods and compositions for treatment of pain via craniofacial mucosal administration of an analgesic compound (e.g. a non-opioid analgesic peptide, an NOP agonist or N/OFQ). Intranasal administration of certain analgesic peptides such as N/OFQ results in global analgesic effects.

2011-01-27

20110021427

BIPHASIC CALCIUM PHOSPHATE CEMENT FOR DRUG DELIVERY - This invention relates to biomineral-based cements incorporating biopolymer carriers for the site specific introduction of natural or synthetic compounds that influence bone repair and/or patient recovery. The invention further relates to methods for producing such biphasic calcium phosphate cements for drug delivery.

2011-01-27

20110021428

PREVENTION OF ALLERGY AT WEANING - A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-β per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.

2011-01-27

20110021429

Renoprotection by growth hormone-releasing hormone and agonists - The present invention relates to renoprotection by growth hormone-releasing hormone and agonists. More specifically, the present invention relates to methods for protecting a mammal against oxidative renal damage, of promoting regeneration of kidney cells in a mammal in need thereof and/or of preventing the death of kidney cells due to oxidative stress. The present invention also relates to the identification of rat and human renal GHRH-R sequences.

2011-01-27

20110021430

MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES - The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.

MANUFACTURE OF FACTOR H (FH) AND FH-DERIVATIVES FROM PLASMA - The present invention provides compositions and pharmaceutical formulations of Factor H derived from plasma. Also provided are methods for the manufacture of the Factor H compositions and formulations, as well as methods for the treatment of diseases associated with Factor H dysfunction.

2011-01-27

20110021433

METHODS FOR TREATING OR PREVENTING HEART FAILURE - The invention provides methods for inhibiting cell death or inflammation in a mammal brought about by diseases or conditions such as heart failure, wherein the method comprises administering to a mammal in need thereof a Bcl protein in an amount sufficient to inhibit cell death and inflammation in the mammal.

2011-01-27

20110021434

Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof - The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.

2011-01-27

20110021435

COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES - The present invention relates to a composition for preventing or treating neurological diseases, particularly brain diseases and improving cognitive functions by inhibiting apoptosis of neuronal cells and/or promoting generation of neuronal cells. The present invention provide a composition for preventing or treating a neurological disease, particularly brain disease, and a composition for improving a cognitive function, which comprises stanniocalcin 2 as an active ingredient.

2011-01-27

20110021436

METHOD FOR REDUCING PAIN WITH ZICONOTIDE AND MORPHINE - The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivacaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ω-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, an antioxidant, in combination with an analgesic selected from the group consisting of morphine, bupivacaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.

2011-01-27

20110021437

METHOD FOR REDUCING PAIN WITH ZICONOTIDE AND BACLOFEN - The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivacaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ω-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, an antioxidant, in combination with an analgesic selected from the group consisting of morphine, bupivacaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.